-
Economic Impact of Smart Infusion Pump Interoperability: A Cost-Benefit Analysis
Mar 10, 2025, 14:00 PM -
Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in the United States Food and Drug Administration (FDA) Labels
Mar 10, 2025, 14:00 PM -
The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study
Mar 10, 2025, 14:00 PM -
What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Mar 10, 2025, 14:00 PM -
Increase in Healthcare Professionals' Willingness to Counsel HPV Vaccine Hesitant Parents Post-Pandemic: Results from a National Survey
Mar 10, 2025, 14:00 PM -
Patient Characteristics and Treatment Patterns in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Mar 10, 2025, 14:00 PM -
Hematologist-Oncologist Preferences for Treating Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) using Tyrosine Kinase Inhibitors in Combination with Chemotherapy: A Discrete Choice Experiment
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review
Mar 10, 2025, 14:00 PM -
Productivity Loss And Indirect Costs Of Heart Failure: Analysis Of The Brazilian Social Security System
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness And Value of Information Analyses of Sotorasib Versus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
Mar 10, 2025, 14:00 PM -
Enhancing Methods to Explore Meaningful Change in Patient Interviews: A Case Study in Spinocerebellar Ataxia (SCA)
Mar 10, 2025, 14:00 PM -
The Changing Impact of the Inflation Reduction Act on Payer Utilization Management- Insights from an Ongoing Quantitative Survey
Mar 10, 2025, 14:00 PM -
Association Between Guideline Concordant Treatment and Healthcare Resource Utilization and Clinical Outcomes Among Older Adults Newly Diagnosed with Stage III - IV Melanoma
Mar 10, 2025, 14:00 PM -
Analytical Approaches to Estimate Medication Persistence From Electronic Health Record Data: A Study of Tyrosine Kinase Inhibitors in Patients With Epidermal Growth Factor Receptor-Positive Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Quantifying the Financial Burden of HbA1c Levels: A Retrospective Single-Center Analysis of Healthcare Costs in South Korean Diabetes Patients.
Mar 10, 2025, 14:00 PM -
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Dominican Republic
Mar 10, 2025, 14:00 PM -
Empowering Patients in Observational Research: Leveraging Data Insights for Sustained Engagement and Innovation
Mar 10, 2025, 14:00 PM -
Early Health Outcomes Model on the Impact of Trimodulin in the Management of Patients With Severe Community-Acquired Pneumonia on Invasive Mechanical Ventilation Based on the CIGMA Phase 2 Randomized Placebo-Controlled Trial
Mar 10, 2025, 14:00 PM -
How Does it Stack Up? User Comparison of the Ambu aScope 5 Uretero Against Reusable Ureteroscope Platforms
Mar 10, 2025, 14:00 PM -
Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM
